Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.
Blood eosinophil count is becoming increasingly recognized by the respiratory specialist community as a clinically relevant biomarker to help estimate affective management strategies, but the use is still...
In this Q and A, lead author Andriana Papaioannou, MD, PhD, discusses the role that identification of asthma phenotypes has in asthma diagnosis and management, the potential use of a complete blood cell...
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
In this interview, Payel Gupta, MD, answers our questions on allergic asthma, including risk factors, common comorbidities, prevalence, and management of allergic asthma.
Elizabeth Volkmann, MD, associate professor at UCLA, Director of the Scleroderma Program, and the codirector of UCLA's Connective Tissue Disease-Related Interstitial Lung Disease program, discusses treating...
Adults use health care services more frequently when they are exposed to wildfire smoke, but the use among children is not as clear. Sydney Leibel, MD, MPH, from Rady Children and Hospital, answers our...
A study investigated how the gut microbiome affects inflammation in the lungs. We caught up with lead author Xin Li, DVM, PhD, from Weill Cornell Medicine, to ask him about this research.
